Evidence map›Paper›PMID 33845284›Full record

ArticleJournal of neuroimmunology2021

IgG intrathecal synthesis in HIV-associated neurocognitive disorder (HAND) according to the HIV-1 subtypes and pattern of HIV RNA in CNS and plasma compartments.

Sergio M De Almeida, Indianara Rotta, Bin Tang, Florin Vaida, Scott Letendre, Ronald J Ellis, HNRC Group

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroimmunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Cerebrospinal Fluid CXCL13 as Candidate Biomarker of Intrathecal Immune Activation, IgG Synthesis and Neurocognitive Impairment in People with HIV.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2023
    Article
  5. Cerebrospinal fluid CD14Journal of neurovirology · 2023
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Sergio M De AlmeidaUniversidade Federal do Paraná, Curitiba, Paraná, Brazil. Electronic address: sergio.ma@ufpr.br.
Indianara RottaUniversidade Federal do Paraná, Curitiba, Paraná, Brazil.
Bin TangDepartment of Psychiatry, University of California, San Diego, CA, USA.
Florin VaidaDivision of Biostatistics and Bioinformatics, Department of Family Medicine and Public Health, University of California, San Diego, CA, USA.
Scott LetendreDivision of Infectious Diseases, Department of Medicine, University of California, San Diego, CA, USA.
Ronald J EllisDepartment of Neurosciences, University of California, San Diego, CA, USA; HIV Neurobehavioral Research Center, University of California, San Diego, San Diego, CA, USA.
HNRC GroupHIV Neurobehavioral Research Center, University of California, San Diego, San Diego, CA, USA.
University of California, San Diego · USUniversidade Federal do Paraná · BR

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jennifer E Iudicello · 2001 to 2026
$50.4M
HIV Clade on Cognitive and Neurological Disorders BrazilR21MH076651 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELLIS, RONALD J. · 2006 to 2007
$317k
NCATS NIH HHS UL1 TR001442NIAID NIH HHS P30 AI036214NIMH NIH HHS P30 MH062512NIMH NIH HHS R21 MH076651
6 · The paper itself

Abstract

We hypothesized that humoral immunity stimulation in the CNS in HIV-1C patients would be lower than that in HIV-1B due to a defective Tat chemokine dimotif (C30C31) that might influence cellular trafficking and CNS inflammation. Sixty-eight paired CSF and blood samples from people with HIV (PWH), free of CNS opportunistic infections, were included, HIV-1B (n = 27), HIV-1C (n = 26), and HIV negative (n = 25). IgG intrathecal synthesis was assayed using quantitative and qualitative methods. IgG oligoclonal bands (OCB) in CSF were observed in 51% of PWH, comparable between HIV-1B and HIV-1C, as well as the medians of IgG intrathecal synthesis formulas. The group with HIV infection aviremic in CSF and blood showed 75% of OCB. There was a poor positive correlation between the IgG quotient and GDS. The impact of HIV-1 on IgG intrathecal production was not subtype dependent. Low-grade CNS intrathecal IgG production persists in HIV CNS infection even in PWH with CSF and blood HIV RNA controlled.

Indexed as

AdultAIDS Dementia ComplexBiomarkersCross-Sectional StudiesFemaleHIV-1HIV InfectionsHumansImmunoglobulin GMaleMiddle AgedRNA, ViralSpinal PunctureBiomarkersImmunoglobulin GRNA, ViralCerebrospinal fluid (CSF)DiscordanceHANDHIV-1IgG synthesisSubtypes

Identifiers

PMID33845284
PMCPMC8102367
OpenAlexW3134901541

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.